Loss of JNK2 increases intestinal tumor susceptibility in Apc1638+/- mice with dietary modulation.

A recent study has shown that c-Jun NH2-terminal kinases (JNKs) 2 interacts with and inhibits β-catenin signaling in vitro. To determine the role of genetic interaction between JNK2 and β-catenin in vivo and to elucidate JNK2-mediated intestinal carcinogenesis, we crossed the JNK2-/- mice with Apc1638+/- mice that carry inactivated Apc allele and develop intestinal tumor due to β-catenin activation. We found that the introduction of mutant JNK2 into Apc1638+/- mice did not increase intestinal tumorigenesis when the mice were fed a defined AIN-76A control diet. However, loss of JNK2 significantly increased animal body weight in the Apc/JNK2+/- and Apc/JNK2-/- mice. Surprisingly, JNK2 loss was synergistic with a Western-style high-risk diet (high fat and phosphate and low calcium and vitamin D) to accelerate intestinal tumorigenesis. Tumor number increased to 3.56 from 1.89 (on AIN-76A diet) in the Apc/JNK2+/- mice (P<0.01) and increased to 4.14 from 1.92 (on AIN-76A diet) in the Apc/JNK2-/- mice (P<0.01) although there was a slight increase of tumor formation in Apc/JNK2+/+ mice. Intestinal tumorigenesis in Apc/JNK2 double-mutant mice with high-risk diet modulation was associated with β-catenin signaling, peroxisome proliferator-activated receptor-γ and inflammation pathway. Collectively, we concluded that JNK2 may function in controlling fat metabolism and loss of JNK2 increases the risk of obesity, the latter synergizes with high-fat diet to increase intestinal tumor susceptibility. This data strongly suggests the importance of JNK2 in intestinal carcinogenesis and the importance of dietary manipulation for cancer prevention in the population whose JNK2 is inactivated.

[1]  C. Rosen,et al.  PPARγ: a circadian transcription factor in adipogenesis and osteogenesis , 2010, Nature Reviews Endocrinology.

[2]  Wancai Yang,et al.  Black Raspberries Inhibit Intestinal Tumorigenesis in Apc1638+/− and Muc2−/− Mouse Models of Colorectal Cancer , 2010, Cancer Prevention Research.

[3]  A. Mantovani,et al.  Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer , 2010, Oncogene.

[4]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[5]  S. Andreadis,et al.  JNK phosphorylates β‐catenin and regulates adherens junctions , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  Wancai Yang,et al.  GSK3β Is Involved in JNK2-Mediated β-Catenin Inhibition , 2009, PloS one.

[7]  B. Spencer‐Dene,et al.  The Links between Transcription, β-catenin/JNK Signaling, and Carcinogenesis , 2009, Molecular Cancer Research.

[8]  M. Czaja,et al.  Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance , 2009, Hepatology.

[9]  Wancai Yang,et al.  c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway. , 2008, Carcinogenesis.

[10]  Wan-Cai Yang,et al.  Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. , 2008, Cancer research.

[11]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[12]  David A. Williams,et al.  Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling , 2008, Cell.

[13]  M. Taketo,et al.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.

[14]  Jiahuai Han,et al.  A beta-catenin-independent dorsalization pathway activated by Axin/JNK signaling and antagonized by aida. , 2007, Developmental cell.

[15]  Wancai Yang,et al.  c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. , 2007, The American journal of pathology.

[16]  Inke Näthke,et al.  Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC , 2006, Nature Reviews Cancer.

[17]  C. Kuan,et al.  Jun NH2-terminal kinase (JNK) prevents nuclear β-catenin accumulation and regulates axis formation in Xenopus embryos , 2006, Proceedings of the National Academy of Sciences.

[18]  Wancai Yang,et al.  Dietary components modify gene expression: implications for carcinogenesis. , 2005, The Journal of nutrition.

[19]  Wancai Yang,et al.  p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse. , 2005, Cancer research.

[20]  Axel Behrens,et al.  Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development , 2005, Nature.

[21]  R. Wolff,et al.  Interactions of Peroxisome Proliferator–Activated Receptor γ and Diet in Etiology of Colorectal Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[22]  J. Potter,et al.  PPARγ, Energy Balance, and Associations With Colon and Rectal Cancer , 2005 .

[23]  E. Wagner,et al.  Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. , 2004, Molecular cell.

[24]  R. Bostick,et al.  The PPARγ Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas , 2004 .

[25]  Wancai Yang,et al.  Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. , 2003, Cancer research.

[26]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[27]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[28]  Andrew J. Wilson,et al.  Environment-gene interactions in intestinal cancer. , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[29]  A. Bode,et al.  Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. , 2002, Cancer research.

[30]  M. Pignatelli,et al.  β-catenin - A linchpin in colorectal carcinogenesis? , 2002 .

[31]  Weiya Ma,et al.  Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. , 2001, Cancer research.

[32]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[33]  R. Flavell,et al.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.

[34]  J. Auwerx,et al.  The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene* , 1997, The Journal of Biological Chemistry.

[35]  X. Chen,et al.  Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R Fodde,et al.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Lipkin,et al.  Colonic hyperproliferation induced in rats and mice by nutritional-stress diets containing four components of a human Western-style diet (series 2). , 1991, The American journal of clinical nutrition.

[38]  M. Lipkin,et al.  Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. , 1990, Journal of the National Cancer Institute.

[39]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[40]  R. Bostick,et al.  The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. , 2005, Carcinogenesis.

[41]  J. Potter,et al.  PPARgamma, energy balance, and associations with colon and rectal cancer. , 2005, Nutrition and cancer.

[42]  M. Pignatelli,et al.  Beta-catenin--a linchpin in colorectal carcinogenesis? , 2002, The American journal of pathology.

[43]  R. Kucherlapati,et al.  Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. , 2001, Cancer research.

[44]  R. Kucherlapati,et al.  Targeted Inactivation of the p21WAF1/cip1 Gene Enhances Apc-initiated Tumor Formation and the Tumor-promoting Activity of a Western-Style High-Risk Diet by Altering Cell Maturation in the Intestinal Mucosa , 2001 .